Cargando…

PPARs as Metabolic Sensors and Therapeutic Targets in Liver Diseases

Carbohydrates and lipids are two components of the diet that provide the necessary energy to carry out various physiological processes to help maintain homeostasis in the body. However, when the metabolism of both biomolecules is altered, development of various liver diseases takes place; such as me...

Descripción completa

Detalles Bibliográficos
Autores principales:	Monroy-Ramirez, Hugo Christian, Galicia-Moreno, Marina, Sandoval-Rodriguez, Ana, Meza-Rios, Alejandra, Santos, Arturo, Armendariz-Borunda, Juan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8347792/ https://www.ncbi.nlm.nih.gov/pubmed/34361064 http://dx.doi.org/10.3390/ijms22158298

Ejemplares similares

Molecular Mechanisms of Obesity-Linked Cardiac Dysfunction: An Up-Date on Current Knowledge
por: Gutiérrez-Cuevas, Jorge, et al.
Publicado: (2021)

Liver Cancer: Therapeutic Challenges and the Importance of Experimental Models
por: Galicia-Moreno, Marina, et al.
Publicado: (2021)

Hepatocarcinogenesis Prevention by Pirfenidone Is PPARγ Mediated and Involves Modification of Nuclear NF-kB p65/p50 Ratio
por: Silva-Gomez, Jorge Antonio, et al.
Publicado: (2021)

Pirfenidone Is an Agonistic Ligand for PPARα and Improves NASH by Activation of SIRT1/LKB1/pAMPK
por: Sandoval‐Rodriguez, Ana, et al.
Publicado: (2020)

The Role of NRF2 in Obesity-Associated Cardiovascular Risk Factors
por: Gutiérrez-Cuevas, Jorge, et al.
Publicado: (2022)

Roles of Nrf2 in Liver Diseases: Molecular, Pharmacological, and Epigenetic Aspects
por: Galicia-Moreno, Marina, et al.
Publicado: (2020)

Hydrodynamics-based liver transfection achieves gene silencing of CB1 using short hairpin RNA plasmid in cirrhotic rats
por: Díaz-Rivera, Adriana, et al.
Publicado: (2020)

Therapies Based on Nanoparticles for Eye Drug Delivery
por: Meza-Rios, Alejandra, et al.
Publicado: (2020)

Oxidative and Fibrinolytic Mechanisms: Two Important Processes to Consider in Platelet Storage
por: Garcia-Bañuelos, Jesus Javier, et al.
Publicado: (2023)

Pirfenidone Protects from UVB-Induced Photodamage in Hairless Mice
por: Martinez-Alvarado, Yocasta, et al.
Publicado: (2023)

Simultaneous Administration of ADSCs-Based Therapy and Gene Therapy Using Ad-huPA Reduces Experimental Liver Fibrosis
por: Meza-Ríos, Alejandra, et al.
Publicado: (2016)

Mexican Ancestral Foods (Theobroma cacao, Opuntia ficus indica, Persea americana and Phaseolus vulgaris) Supplementation on Anthropometric, Lipid and Glycemic Control Variables in Obese Patients: A Systematic Review and Meta-Analysis
por: Escutia-Gutiérrez, Rebeca, et al.
Publicado: (2023)

Moringa oleifera Improves MAFLD by Inducing Epigenetic Modifications
por: Monraz-Méndez, C. Alejandra, et al.
Publicado: (2022)

Fibrosis regression is induced by AdhMMP8 in a murine model of chronic kidney injury
por: Contreras-Salinas, Homero, et al.
Publicado: (2020)

An Update in Epigenetics in Metabolic-Associated Fatty Liver Disease
por: Rodríguez-Sanabria, J. Samael, et al.
Publicado: (2022)

Editorial: Liver Fibrosis and MAFLD: From Molecular Aspects to Novel Pharmacological Strategies
por: Sandoval-Rodriguez, Ana, et al.
Publicado: (2022)

Epidemiologic, Genetic, Pathogenic, Metabolic, Epigenetic Aspects Involved in NASH-HCC: Current Therapeutic Strategies
por: Gutiérrez-Cuevas, Jorge, et al.
Publicado: (2022)

Dietary supplementation with Mexican foods, Opuntia ficus indica, Theobroma cacao, and Acheta domesticus: Improving obesogenic and microbiota features in obese mice
por: Rosas-Campos, Rebeca, et al.
Publicado: (2022)

Molecular Mechanisms during Hepatitis B Infection and the Effects of the Virus Variability
por: Campos-Valdez, Marina, et al.
Publicado: (2021)

Molecular Basis and Current Treatment for Alcoholic Liver Disease
por: Miranda-Mendez, Alejandra, et al.
Publicado: (2010)

Pathophysiological Molecular Mechanisms of Obesity: A Link between MAFLD and NASH with Cardiovascular Diseases
por: Gutiérrez-Cuevas, Jorge, et al.
Publicado: (2021)

Pirfenidone modifies hepatic miRNAs expression in a model of MAFLD/NASH
por: Escutia-Gutiérrez, Rebeca, et al.
Publicado: (2021)

Delphinidin Ameliorates Hepatic Triglyceride Accumulation in Human HepG2 Cells, but Not in Diet-Induced Obese Mice
por: Parra-Vargas, Marcela, et al.
Publicado: (2018)

Toward a New Generation of Bio-Scaffolds for Neural Tissue Engineering: Challenges and Perspectives
por: Villanueva-Flores, Francisca, et al.
Publicado: (2023)

The multifaceted role of pirfenidone and its novel targets
por: Macías-Barragán, José, et al.
Publicado: (2010)

PPARs as Metabolic Regulators in the Liver: Lessons from Liver-Specific PPAR-Null Mice
por: Wang, Yaping, et al.
Publicado: (2020)

Topical Pirfenidone-Loaded Liposomes Ophthalmic Formulation Reduces Haze Development after Corneal Alkali Burn in Mice
por: Diaz-Palomera, Carlos Daniel, et al.
Publicado: (2022)

Advances of Nanotechnology in the Diagnosis and Treatment of Hepatocellular Carcinoma
por: Escutia-Gutiérrez, Rebeca, et al.
Publicado: (2023)

AdhMMP8 Vector Administration in Muscle: An Alternate Strategy to Regress Hepatic Fibrosis
por: García-Bañuelos, Jesús, et al.
Publicado: (2023)

Nutraceuticals: A Promising Therapeutic Approach in Ophthalmology
por: Castro-Castaneda, Carlos Rodrigo, et al.
Publicado: (2022)

Diet switch and omega-3 hydroxy-fatty acids display differential hepatoprotective effects in an obesity/nonalcoholic fatty liver disease model in mice
por: Rodriguez-Echevarria, Roberto, et al.
Publicado: (2018)

Therapeutic potential of PPARγ natural agonists in liver diseases
por: Wu, Liwei, et al.
Publicado: (2020)

Protective Effects of Moringa oleifera on HBV Genotypes C and H Transiently Transfected Huh7 Cells
por: Feustel, Sina, et al.
Publicado: (2017)

PPARs and Liver Disease
por: Kondo, Yasuteru, et al.
Publicado: (2013)

Is the Mouse a Good Model of Human PPARγ-Related Metabolic Diseases?
por: Pap, Attila, et al.
Publicado: (2016)

PPARβ/δ: A Key Therapeutic Target in Metabolic Disorders
por: Palomer, Xavier, et al.
Publicado: (2018)

PPARδ: A Potential Therapeutic Target for the Treatment of Metabolic Hypertension
por: Jiang, Yanli, et al.
Publicado: (2019)

Safety and Tolerability of Topical Ophthalmic Triamcinolone Acetonide-Loaded Liposomes Formulation and Evaluation of Its Biologic Activity in Patients with Diabetic Macular Edema
por: Navarro-Partida, Jose, et al.
Publicado: (2021)

PPARs and Bone Metabolism
por: Lecka-Czernik, Beata
Publicado: (2006)

PPARs and Metabolic Syndrome
por: Chen, Lihong, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_ieqbsha48tb0ji38has4t54gsm